Cymabay Therapeu Price on December 28, 2022

CBAYDelisted Stock  USD 11.83  0.27  2.34%   
If you're considering investing in Cymabay Stock, it is important to understand the factors that can impact its price. As of today, the current price of Cymabay Therapeu stands at 11.83, as last reported on the 10th of January, with the highest price reaching 12.43 and the lowest price hitting 11.52 during the day. We have found thirty technical indicators for Cymabay Therapeu, which you can use to evaluate the volatility of the firm. Please confirm Cymabay Therapeu's Risk Adjusted Performance of 0.0627, downside deviation of 3.68, and Mean Deviation of 3.0 to double-check if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Cymabay Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
CBAY
Based on monthly moving average Cymabay Therapeu is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cymabay Therapeu by adding Cymabay Therapeu to a well-diversified portfolio.

Related Headline

Structure Therapeutics Headline on 2nd of February 2023

Filed transaction by Structure Therapeutics In officer. Unconventional Insider trading

Cymabay Therapeu Valuation on December 28, 2022

It is possible to determine the worth of Cymabay Therapeu on a given historical date. On December 28, 2022 Cymabay was worth 5.53 at the beginning of the trading date compared to the closed value of 5.54. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Cymabay Therapeu stock. Still, in general, we apply an absolute valuation method to find Cymabay Therapeu's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cymabay Therapeu where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Cymabay Therapeu's related companies.
 Open High Low Close Volume
  5.51    5.57    5.27    5.52    1,176,072  
12/28/2022
  5.53    5.63    5.41    5.54    1,073,539  
  5.56    6.09    5.56    6.05    1,269,289  
Backtest Cymabay Therapeu  |  Cymabay Therapeu History  |  Cymabay Therapeu Valuation   PreviousNext  
Open Value
5.53
5.54
Closing Value
5.53
Upside

Cymabay Therapeu Trading Date Momentum on December 28, 2022

On December 29 2022 Cymabay Therapeu was traded for  6.05  at the closing time. The top price for the day was 6.09  and the lowest listed price was  5.56 . The trading volume for the day was 1.3 M. The trading history from December 29, 2022 was a factor to the next trading day price jump. The overall trading delta against the next closing price was 9.21% . The overall trading delta against the current closing price is 16.61% .

Cymabay Therapeu Fundamentals Correlations and Trends

By evaluating Cymabay Therapeu's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Cymabay Therapeu's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Cymabay financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Cymabay Therapeu Stock history

Cymabay Therapeu investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cymabay is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cymabay Therapeu will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cymabay Therapeu stock prices may prove useful in developing a viable investing in Cymabay Therapeu
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. CymaBay Therapeutics, Inc. was incorporated in 1988 and is headquartered in Newark, California. Cymabay Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 59 people.

Cymabay Therapeu Stock Technical Analysis

Cymabay Therapeu technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Cymabay Therapeu technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Cymabay Therapeu trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Cymabay Therapeu Period Price Range

Low
January 10, 2025
0.00  NaN%
High

 0.00 

     

 0.00 

Cymabay Therapeu cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Cymabay Therapeu January 10, 2025 Market Strength

Market strength indicators help investors to evaluate how Cymabay Therapeu stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cymabay Therapeu shares will generate the highest return on investment. By undertsting and applying Cymabay Therapeu stock market strength indicators, traders can identify Cymabay Therapeu entry and exit signals to maximize returns

Cymabay Therapeu Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Cymabay Therapeu's price direction in advance. Along with the technical and fundamental analysis of Cymabay Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cymabay to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Other Consideration for investing in Cymabay Stock

If you are still planning to invest in Cymabay Therapeu check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cymabay Therapeu's history and understand the potential risks before investing.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Fundamental Analysis
View fundamental data based on most recent published financial statements
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Commodity Directory
Find actively traded commodities issued by global exchanges
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account